C. Mandet, M. F. Belair, P. Bruneval, O. Meilhac, B. Bellon et al., Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response, Proc Natl Acad Sci, vol.102, pp.14723-14728, 2005.

O. Thaunat, N. Patey, E. Morelon, J. B. Michel, and A. Nicoletti, Lymphoid neogenesis in chronic rejection: the murderer is in the house, Curr Opin Immunol, vol.18, pp.576-579, 2006.

A. Haririan, B. Kiangkitiwan, D. Kukuruga, M. Cooper, H. Hurley et al., The impact of c4d pattern and donorspecific antibody on graft survival in recipients requiring indication renal allograft biopsy, Am J Transplant, vol.9, pp.2758-2767, 2009.

A. Piazza, E. Poggi, L. Borrelli, S. Servetti, P. I. Monaco et al., Impact of donorspecific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques, Transplantation, vol.71, pp.1106-1112, 2001.

S. Nakashima, Z. Qian, S. Rahimi, B. A. Wasowska, and W. M. Baldwin, Membrane attack complex contributes to destruction of vascular integrity in acute lung allograft rejection, J Immunol, vol.169, pp.4620-4627, 2002.

P. N. Rocha, T. J. Plumb, S. D. Crowley, and T. M. Coffman, Effector mechanisms in transplant rejection, Immunol Rev, vol.196, pp.51-64, 2003.

R. B. Colvin and R. N. Smith, Antibody-mediated organ-allograft rejection, Nat Rev Immunol, vol.5, pp.807-817, 2005.

A. T. Chang and J. L. Platt, The role of antibodies in transplantation, Transplant Rev (Orlando), vol.23, pp.191-198, 2009.

X. Zhang and E. F. Reed, Effect of antibodies on endothelium, Am J Transplant, vol.9, pp.2459-2465, 2009.

P. Stashenko, L. M. Nadler, R. Hardy, and S. F. Schlossman, Characterization of a human B lymphocyte-specific antigen, J Immunol, vol.125, pp.1678-1685, 1980.

P. Fiorina and M. H. Sayegh, B cell-targeted therapies in autoimmunity: rationale and progress, F1000 Biol Rep, vol.1, p.39, 2009.

T. Fehr, B. Rüsi, A. Fischer, H. Hopfer, R. P. Wüthrich et al., Rituximab and intravenous immunoglobulin treatment of chronic antibody-mediated kidney allograft rejection, Transplan tation, vol.87, pp.1837-1841, 2009.

P. Fiorina, A. Vergani, S. Dada, M. Jurewicz, M. Wong et al., Targeting CD22 reprograms B-cells and reverses autoimmune diabetes, Diabetes, vol.57, pp.3013-3024, 2008.

M. Carvello, A. Petrelli, A. Vergani, K. M. Lee, S. Tezza et al., Inotuzumab ozogamicin murine analog-mediated B-cell depletion reduces anti-islet alloand autoimmune responses, Diabetes, vol.61, pp.155-165, 2012.

T. Dörner, J. Kaufmann, W. A. Wegener, N. Teoh, D. M. Goldenberg et al., Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus, Arthritis Res Ther, vol.8, 2006.

Y. Vugmeyster, D. Seshasayee, W. Chang, A. Storn, K. Howell et al., A soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeys, Am J Pathol, vol.168, pp.476-489, 2006.

J. L. Scholz, J. E. Crowley, M. M. Tomayko, N. Steinel, P. J. O'neill et al., BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact, Proc Natl Acad Sci, vol.105, pp.15517-15522, 2008.

G. Zekavat, S. Y. Rostami, A. Badkerhanian, R. F. Parsons, B. Koeberlein et al., In vivo BLyS/BAFF neutralization ameliorates islet-directed autoimmunity in nonobese diabetic mice, J Immunol, vol.181, pp.8133-8144, 2008.

Q. Ye, L. Wang, A. D. Wells, R. Tao, R. Han et al., BAFF binding to T cell-expressed BAFF-R costimulates T cell proliferation and alloresponses, Eur J Immunol, vol.34, pp.2750-2759, 2004.

R. F. Parsons, M. Yu, K. Vivek, G. Zekavat, S. Y. Rostami et al., Murine islet allograft tolerance upon blockade of the B-lymphocyte stimulator, BLyS/BAFF. Transplantation, vol.93, pp.676-685, 2012.

E. M. Ginzler, S. Wax, A. Rajeswaran, S. Copt, J. Hillson et al., Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial, Arthritis Res Ther, vol.14, p.33, 2012.

R. Furie, M. Petri, O. Zamani, R. Cervera, D. J. Wallace et al.,

R. F. Vollenhoven, A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus, Arthritis Rheum, vol.63, 2011.

R. M. Anthony, F. Nimmerjahn, D. J. Ashline, V. N. Reinhold, J. C. Paulson et al., Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc, Science, vol.320, pp.373-376, 2008.

D. K. Perry, J. M. Burns, H. S. Pollinger, B. P. Amiot, J. M. Gloor et al., Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production, Am J Transplant, vol.9, pp.201-209, 2009.

R. C. Walsh, R. R. Alloway, A. L. Girnita, and E. S. Woodle, Proteasome inhibitor-based therapy for antibody-mediated rejection, Kidney Int, vol.81, pp.1067-1074, 2012.

M. D. Stegall, T. Diwan, S. Raghavaiah, L. D. Cornell, J. Burns et al., Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients, Am J Transplant, vol.11, pp.2405-2413, 2011.

G. Vitale, F. Mion, and C. Pucillo, Regulatory B cells: evidence, developmental origin and population diversity, Mol Immunol, vol.48, pp.1-8, 2010.
DOI : 10.1016/j.molimm.2010.09.010

C. Mauri and A. Bosma, Immune regulatory function of B cells, Annu Rev Immunol, vol.30, pp.221-241, 2012.

A. Morris and G. Möller, Regulation of cellular antibody synthesis effect of adoptively transferred antibody-producing spleen cells on cellular antibody synthesis, J Immunol, vol.101, pp.439-445, 1968.

S. I. Katz, D. Parker, and J. L. Turk, B-cell suppression of delayed hypersensitivity reactions, Nature, vol.251, pp.550-551, 1974.

S. I. Katz, D. Parker, G. Sommer, and J. L. Turk, Suppressor cells in normal immunisation as a basic homeostatic phenomenon, Nature, vol.248, pp.612-614, 1974.

S. D. Wolf, B. N. Dittel, F. Hardardottir, and C. A. Janeway, Experimental autoimmune encephalomyelitis induction in genetically B celldeficient mice, J Exp Med, vol.184, pp.2271-2278, 1996.

C. Mauri, D. Gray, N. Mushtaq, and M. Londei, Prevention of arthritis by interleukin 10-producing B cells, J Exp Med, vol.197, pp.489-501, 2003.

P. Lenert, R. Brummel, E. H. Field, and R. F. Ashman, TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production, J Clin Immunol, vol.25, pp.29-40, 2005.

S. Hussain and T. L. Delovitch, Intravenous transfusion of BCRactivated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner, J Immunol, vol.179, pp.7225-7232, 2007.

A. Mizoguchi, E. Mizoguchi, R. N. Smith, F. I. Preffer, and A. K. Bhan, Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice, J Exp Med, vol.186, pp.1749-1756, 1997.

M. Horikawa, E. T. Weimer, D. J. Dilillo, G. M. Venturi, R. Spolski et al., Regulatory B cell (B10 Cell) expansion during Listeria infection governs innate and cellular immune responses in mice, J Immunol, vol.190, pp.1158-1168, 2013.

B. Siewe, J. T. Stapleton, J. Martinson, A. Keshavarzian, N. Kazmi et al., Regulatory B cell frequency correlates with markers of HIV disease progression and attenuates anti-HIV CD8

, + T cell function in vitro, J Leukoc Biol, vol.93, pp.811-818, 2013.

M. Horikawa, V. Minard-colin, T. Matsushita, and T. F. Tedder, Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice, J Clin Invest, vol.121, pp.4268-4280, 2011.

D. C. Parker, D. L. Greiner, N. E. Phillips, M. C. Appel, A. W. Steele et al., Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand, Proc Natl Acad Sci, vol.92, pp.9560-9564, 1995.

M. Niimi, T. C. Pearson, C. P. Larsen, D. Z. Alexander, D. Hollenbaugh et al., The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivo, J Immunol, vol.161, pp.5331-5337, 1998.

Y. Yan, K. Van-der-putten, D. G. Bowen, D. M. Painter, J. Kohar et al., Postoperative administration of donor B cells induces rat kidney allograft acceptance: lack of association with Th2 cytokine expression in long-term accepted grafts, Transplantation, vol.73, pp.1123-1130, 2002.

S. Deng, D. J. Moore, X. Huang, M. M. Lian, M. Mohiuddin et al., Cutting edge: transplant tolerance induced by anti-CD45RB requires B lymphocytes, J Immunol, vol.178, pp.6028-6032, 2007.

Q. Ding, M. Yeung, G. Camirand, Q. Zeng, H. Akiba et al., Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice, J Clin Invest, vol.121, pp.3645-3656, 2011.

K. M. Lee, J. I. Kim, R. Stott, J. Soohoo, M. R. O'connor et al., Anti-CD45RB/ anti-TIM-1-induced tolerance requires regulatory B cells, Am J Transplant, vol.12, pp.2072-2078, 2012.

E. Chiffoleau, G. Bériou, P. Dutartre, C. Usal, J. P. Soulillou et al., Induction of donor-specific allograft tolerance by short-term treatment with LF15-0195 after transplantation. Evidence for a direct effect on T-cell differentiation, Am J Transplant, vol.2, pp.745-757, 2002.

E. Chiffoleau, G. Bériou, P. Dutartre, C. Usal, J. P. Soulillou et al., Role for thymic and splenic regulatory CD4

, + T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment, J Immunol, vol.168, pp.5058-5069, 2002.

L. Texier, L. , T. P. Lavault, A. Usal, C. Merieau et al., Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile, Am J Transplant, vol.11, pp.429-438, 2011.

A. Pallier, S. Hillion, R. Danger, M. Giral, M. Racapé et al., Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype, Kidney Int, vol.78, pp.503-513, 2010.

K. A. Newell, A. Asare, A. D. Kirk, T. D. Gisler, K. Bourcier et al., Identification of a B cell signature associated with renal transplant tolerance in humans, J Clin Invest, vol.120, pp.1836-1847, 2010.

P. Sagoo, E. Perucha, B. Sawitzki, S. Tomiuk, D. A. Stephens et al., Development of a crossplatform biomarker signature to detect renal transplant tolerance in humans, J Clin Invest, vol.120, pp.1848-1861, 2010.

S. Brouard, E. Mansfield, C. Braud, L. Li, M. Giral et al., Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance, Proc Natl Acad Sci, vol.104, pp.15448-15453, 2007.

M. Chesneau, A. Pallier, F. Braza, G. Lacombe, L. Gallou et al., Unique B cell differentiation profile in tolerant kidney transplant patients, Am J Transplant, vol.14, pp.144-155, 2014.
URL : https://hal.archives-ouvertes.fr/hal-00974748

L. Rolle, M. Memarzadeh-tehran, A. Morell-garcía, Y. Raeva, A. Schumacher et al., Cutting edge: IL-10-producing regulatory B cells in early human pregnancy, Am J Reprod Immunol, vol.70, pp.448-453, 2013.

M. R. Clatworthy, C. J. Watson, G. Plotnek, V. Bardsley, A. N. Chaudhry et al., B-cell-depleting induction therapy and acute cellular rejection, N Engl J Med, vol.360, pp.2683-2685, 2009.

J. G. Evans, K. A. Chavez-rueda, A. Eddaoudi, A. Meyer-bahlburg, D. J. Rawlings et al., Novel suppressive function of transitional 2 B cells in experimental arthritis, J Immunol, vol.178, pp.7868-7878, 2007.

K. Yanaba, J. D. Bouaziz, T. Matsushita, T. Tsubata, and T. F. Tedder, The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals, J Immunol, vol.182, pp.7459-7472, 2009.

R. X. Wang, C. R. Yu, I. M. Dambuza, R. M. Mahdi, M. B. Dolinska et al., Interleukin-35 induces regulatory B cells that suppress autoimmune disease, Nat Med, vol.20, pp.633-641, 2014.

V. D. Dang, E. Hilgenberg, S. Ries, P. Shen, and S. Fillatreau, From the regulatory functions of B cells to the identification of cytokineproducing plasma cell subsets, Curr Opin Immunol, vol.28, pp.77-83, 2014.

P. A. Blair, L. Y. Noreña, F. Flores-borja, D. J. Rawlings, D. A. Isenberg et al., CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients, Immunity, vol.32, pp.129-140, 2010.

Y. Iwata, T. Matsushita, M. Horikawa, D. J. Dilillo, K. Yanaba et al., Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells, Blood, vol.117, pp.530-541, 2011.

W. Lin, D. Cerny, E. Chua, K. Duan, J. T. Yi et al., Human regulatory B cells combine phenotypic and genetic hallmarks with a distinct differentiation fate, J Immunol, vol.193, pp.2258-2266, 2014.

A. Khoder, A. Sarvaria, A. Alsuliman, C. Chew, T. Sekine et al., Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD, Blood, vol.124, pp.2034-2045, 2014.

A. O'garra, R. Chang, N. Go, R. Hastings, G. Haughton et al., Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10, Eur J Immunol, vol.22, pp.711-717, 1992.

I. Kalampokis, A. Yoshizaki, and T. F. Tedder, IL-10-producing regulatory B cells (B10 cells) in autoimmune disease, Arthritis Res Ther, vol.15, 2013.

K. Yanaba, J. D. Bouaziz, K. M. Haas, J. C. Poe, M. Fujimoto et al., A regulatory B cell subset with a unique CD1dhiCD5 + phenotype controls T cell-dependent inflammatory responses, Immunity, vol.28, pp.639-650, 2008.

M. Yang, L. Sun, S. Wang, K. H. Ko, H. Xu et al., Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells, J Immunol, vol.184, pp.3321-3325, 2010.

P. Schneider, H. Takatsuka, A. Wilson, F. Mackay, A. Tardivel et al., Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen, J Exp Med, vol.194, pp.1691-1697, 2001.

R. Montandon, S. Korniotis, E. Layseca-espinosa, C. Gras, J. Mégret et al., Innate pro-B-cell progenitors protect against type 1 diabetes by regulating autoimmune effector T cells, Proc Natl Acad Sci, vol.110, pp.2199-2208, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00845005

M. Duddy, M. Niino, F. Adatia, S. Hebert, M. Freedman et al., Bar-Or A. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis, J Immunol, vol.178, pp.6092-6099, 2007.

S. Lemoine, A. Morva, P. Youinou, and C. Jamin, Human T cells induce their own regulation through activation of B cells, J Autoimmun, vol.36, pp.228-238, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00771265

L. A. Herzenberg, B-1 cells: the lineage question revisited, Immunol Rev, vol.175, pp.9-22, 2000.

P. X. Shaw, S. Hörkkö, M. K. Chang, L. K. Curtiss, W. Palinski et al., Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity, J Clin Invest, vol.105, pp.1731-1740, 2000.

C. J. Binder, K. Hartvigsen, M. K. Chang, M. Miller, D. Broide et al., IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis, J Clin Invest, vol.114, pp.427-437, 2004.

A. Mizoguchi, E. Mizoguchi, H. Takedatsu, R. S. Blumberg, and A. K. Bhan, Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation, Immunity, vol.16, pp.219-230, 2002.

S. Fillatreau, C. H. Sweenie, M. J. Mcgeachy, D. Gray, and S. M. Anderton, B cells regulate autoimmunity by provision of IL-10, Nat Immunol, vol.3, pp.944-950, 2002.

K. M. Haas, R. Watanabe, T. Matsushita, H. Nakashima, N. Ishiura et al., Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice, J Immunol, vol.184, pp.4789-4800, 2010.

D. J. Dilillo, J. B. Weinberg, A. Yoshizaki, M. Horikawa, J. M. Bryant et al., Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function, Leukemia, vol.27, pp.170-182, 2013.

P. Shen, T. Roch, V. Lampropoulou, R. A. O'connor, U. Stervbo et al., IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases, Nature, vol.507, pp.366-370, 2014.

S. Ries, E. Hilgenberg, V. Lampropoulou, P. Shen, V. D. Dang et al., B-type suppression: a role played by "regulatory B cells" or "regulatory plasma cells"?, Eur J Immunol, vol.44, pp.1251-1257, 2014.

P. J. Rauch, A. Chudnovskiy, C. S. Robbins, G. F. Weber, M. Etzrodt et al., Innate response activator B cells protect against microbial sepsis, Science, vol.335, pp.597-601, 2012.

J. H. Fritz, O. L. Rojas, N. Simard, D. D. Mccarthy, S. Hapfelmeier et al., Acquisition of a multifunctional IgA + plasma cell phenotype in the gut, Nature, vol.481, pp.199-203, 2012.

S. Kleffel, A. Vergani, S. Tezza, B. Nasr, M. Niewczas et al.,

, + B cells to maintain tolerance to islet autoantigens, Diabetes, vol.64, pp.158-171, 2015.

B. Jahrsdörfer, S. E. Blackwell, J. E. Wooldridge, J. Huang, M. W. Andreski et al., B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation, Blood, vol.108, pp.2712-2719, 2006.

M. Hagn, E. Schwesinger, V. Ebel, K. Sontheimer, J. Maier et al., Human B cells secrete granzyme B when recognizing viral antigens in the context of the acute phase cytokine IL-21, J Immunol, vol.183, pp.1838-1845, 2009.

M. Hagn, V. Ebel, K. Sontheimer, E. Schwesinger, O. Lunov et al., CD5 + B cells from individuals with systemic lupus erythematosus express granzyme B, Eur J Immunol, vol.40, pp.2060-2069, 2010.

M. Hagn, G. T. Belz, A. Kallies, V. R. Sutton, K. Y. Thia et al., Activated mouse B cells lack expression of granzyme B, J Immunol, vol.188, pp.3886-3892, 2012.

C. Kaltenmeier, A. Gawanbacht, T. Beyer, S. Lindner, T. Trzaska et al., , vol.4

, + T cellderived IL-21 and deprivation of CD40 signaling favor the in vivo development of granzyme B-expressing regulatory B cells in HIV patients, J Immunol, vol.194, pp.3768-3777, 2015.

M. Chesneau, L. Michel, . Dugast, A. Chenouard, D. Baron et al., Tolerant Kidney Transplant Patients Produce B Cells with Regulatory Properties, J Am Soc Nephrol, vol.2, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-02148982

M. L. Cupi, M. Sarra, I. Marafini, I. Monteleone, E. Franzè et al., Plasma cells in the mucosa of patients with inflammatory bowel disease produce granzyme B and possess cytotoxic activities, J Immunol, vol.192, pp.6083-6091, 2014.

S. Lindner, K. Dahlke, K. Sontheimer, M. Hagn, C. Kaltenmeier et al., Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells, Cancer Res, vol.73, pp.2468-2479, 2013.

M. Hahne, T. Renno, M. Schroeter, M. Irmler, L. French et al., Activated B cells express functional Fas ligand, Eur J Immunol, vol.26, pp.721-724, 1996.

S. K. Lundy and D. A. Fox, Reduced Fas ligand-expressing splenic CD5 + B lymphocytes in severe collagen-induced arthritis, Arthritis Res Ther, vol.11, 2009.

S. K. Lundy, Killer B lymphocytes: the evidence and the potential, Inflamm Res, vol.58, pp.345-357, 2009.

A. Villunger, A. Egle, I. Marschitz, M. Kos, G. Böck et al., Constitutive expression of Fas (Apo-1/ CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillance, Blood, vol.90, pp.12-20, 1997.

J. E. Tanner and C. Alfieri, Epstein-Barr virus induces Fas (CD95) in T cells and Fas ligand in B cells leading to T-cell apoptosis, Blood, vol.94, pp.3439-3447, 1999.

A. Samuelsson, A. Sönnerborg, N. Heuts, J. Cöster, and F. Chiodi, Progressive B cell apoptosis and expression of Fas ligand during human immunodeficiency virus type 1 infection, AIDS Res Hum Retroviruses, vol.13, pp.1031-1038, 1997.

R. F. Rich, W. J. Cook, and W. R. Green, Spontaneous in vivo retrovirusinfected T and B cells, but not dendritic cells, mediate antigenspecific Fas ligand/Fas-dependent apoptosis of anti-retroviral CTL, Virology, vol.346, pp.287-300, 2006.

J. Tian, D. Zekzer, L. Hanssen, Y. Lu, A. Olcott et al., Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice, J Immunol, vol.167, pp.1081-1089, 2001.

D. Bonardelle, K. Benihoud, N. Kiger, and P. Bobé, B lymphocytes mediate Fas-dependent cytotoxicity in MRL/lpr mice, J Leukoc Biol, vol.78, pp.1052-1059, 2005.

R. Minagawa, S. Okano, Y. Tomita, K. Kishihara, H. Yamada et al., The critical role of Fas-Fas ligand interaction in donor-specific transfusion-induced tolerance to H-Y antigen, Transplantation, vol.78, pp.799-806, 2004.

S. M. Mariani and P. H. Krammer, Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells, Eur J Immunol, vol.28, pp.1492-1498, 1998.

S. M. Mariani and P. H. Krammer, Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage, Eur J Immunol, vol.28, pp.973-982, 1998.

P. Secchiero, M. Tiribelli, E. Barbarotto, C. Celeghini, A. Michelutti et al., Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells, J Cell Physiol, vol.205, pp.246-252, 2005.

M. E. Keir, M. J. Butte, G. J. Freeman, and A. H. Sharpe, PD-1 and its ligands in tolerance and immunity, Annu Rev Immunol, vol.26, pp.677-704, 2008.

T. Yamazaki, H. Akiba, H. Iwai, H. Matsuda, M. Aoki et al., Expression of programmed death 1 ligands by murine T cells and APC, J Immunol, vol.169, pp.5538-5545, 2002.

Y. Latchman, C. R. Wood, T. Chernova, D. Chaudhary, M. Borde et al., PD-L2 is a second ligand for PD-1 and inhibits T cell activation, Nat Immunol, vol.2, pp.261-268, 2001.

A. K. Singh, P. Stock, and O. Akbari, Role of PD-L1 and PD-L2 in allergic diseases and asthma, Allergy, vol.66, pp.155-162, 2011.

X. Zhong, J. R. Tumang, W. Gao, C. Bai, and T. L. Rothstein, PD-L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for V(H)11/V(H)12 and phosphatidylcholine binding, Eur J Immunol, vol.37, pp.2405-2410, 2007.

S. Shalapour, J. Font-burgada, D. Caro, G. Zhong, Z. Sanchezlopez et al., Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy, Nature, vol.521, pp.94-98, 2015.

F. Nimmerjahn and J. V. Ravetch, Fcgamma receptors as regulators of immune responses, Nat Rev Immunol, vol.8, pp.34-47, 2008.

R. B. Parekh, R. A. Dwek, B. J. Sutton, D. L. Fernandes, A. Leung et al., Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG, Nature, vol.316, pp.452-457, 1985.

Y. Kaneko, F. Nimmerjahn, and J. V. Ravetch, Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation, Science, vol.313, pp.670-673, 2006.

R. M. Anthony, F. Wermeling, M. C. Karlsson, and J. V. Ravetch, Identification of a receptor required for the anti-inflammatory activity of IVIG, Proc Natl Acad Sci, vol.105, pp.19571-19578, 2008.

R. M. Anthony, T. Kobayashi, F. Wermeling, and J. V. Ravetch, Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway, Nature, vol.475, pp.110-113, 2011.

J. Wang, C. I. Balog, K. Stavenhagen, C. A. Koeleman, H. U. Scherer et al., Fc-glycosylation of IgG1 is modulated by B-cell stimuli, Mol Cell Proteomics, vol.10, 2011.

H. M. Ashour and J. Y. Niederkorn, Peripheral tolerance via the anterior chamber of the eye: role of B cells in MHC class I and II antigen presentation, J Immunol, vol.176, pp.5950-5957, 2006.

N. A. Carter, R. Vasconcellos, E. C. Rosser, C. Tulone, A. Muñoz-suano et al., Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells, J Immunol, vol.186, pp.5569-5579, 2011.

S. Amu, S. P. Saunders, M. Kronenberg, N. E. Mangan, A. Atzberger et al., Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model, J Allergy Clin Immunol, vol.125, pp.1114-1124, 2010.

J. Zheng, Y. Liu, G. Qin, P. L. Chan, H. Mao et al., Efficient induction and expansion of human alloantigenspecific CD8 regulatory T cells from naive precursors by CD40-activated B cells, J Immunol, vol.183, pp.3742-3750, 2009.

J. Zheng, Y. Liu, Y. L. Lau, and W. Tu, CD40-activated B cells are more potent than immature dendritic cells to induce and expand CD4(+) regulatory T cells, Cell Mol Immunol, vol.7, pp.44-50, 2010.

C. A. Koch, Z. I. Khalpey, and J. L. Platt, Accommodation: preventing injury in transplantation and disease, J Immunol, vol.172, pp.5143-5148, 2004.

F. H. Bach, W. W. Hancock, and C. Ferran, Protective genes expressed in endothelial cells: a regulatory response to injury, Immunol Today, vol.18, issue.97, pp.1129-1137, 1997.

F. H. Bach, C. Ferran, P. Hechenleitner, W. Mark, N. Koyamada et al., Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment, Nat Med, vol.3, pp.196-204, 1997.

J. M. Heslan, K. Renaudin, P. Thebault, R. Josien, M. C. Cuturi et al., New evidence for a role of allograft accommodation in long-term tolerance, Transplantation, vol.82, pp.1185-1193, 2006.

M. P. Soares, M. P. Seldon, I. P. Gregoire, T. Vassilevskaia, P. O. Berberat et al., Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation, J Immunol, vol.172, pp.3553-3563, 2004.

M. P. Soares, Y. Lin, K. Sato, K. M. Stuhlmeier, and F. H. Bach, Accommodation, Immunol Today, vol.20, pp.434-437, 1999.

M. P. Soares, Y. Lin, J. Anrather, E. Csizmadia, K. Takigami et al., Expression of heme oxygenase-1 can determine cardiac xenograft survival, Nat Med, vol.4, pp.1073-1077, 1998.

M. P. Soares, S. Brouard, R. N. Smith, and F. H. Bach, Heme oxygenase-1, a protective gene that prevents the rejection of transplanted organs, Immunol Rev, vol.184, pp.275-285, 2001.

W. Van-de-veen, B. Stanic, G. Yaman, M. Wawrzyniak, S. Söllner et al., IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses, J Allergy Clin Immunol, vol.131, pp.1204-1212, 2013.

F. Meiler, J. Zumkehr, S. Klunker, B. Rückert, C. A. Akdis et al., In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure, J Exp Med, vol.205, pp.2887-2898, 2008.

S. Shabir, J. Girdlestone, D. Briggs, B. Kaul, H. Smith et al., Transitional B lymphocytes are associated with protection from kidney allograft rejection: a prospective study, Am J Transplant, vol.15, pp.1384-1391, 2015.

A. Nouël, I. Ségalen, C. Jamin, L. Doucet, S. Caillard et al., B cells display an abnormal distribution and an impaired suppressive function in patients with chronic antibody-mediated rejection, Kidney Int, vol.85, pp.590-599, 2014.

R. F. Parsons, K. Vivek, S. Y. Rostami, G. Zekavat, S. M. Ziaie et al., Acquisition of humoral transplantation tolerance upon de novo emergence of B lymphocytes, J Immunol, vol.186, pp.614-620, 2011.

S. Heidt, J. Hester, S. Shankar, P. J. Friend, and K. J. Wood, B cell repopulation after alemtuzumab induction-transient increase in transitional B cells and long-term dominance of naive B cells, Am J Transplant, vol.12, pp.1784-1792, 2012.

A. Cherukuri, A. D. Salama, C. Carter, N. Smalle, R. Mccurtin et al., An analysis of lymphocyte phenotype after steroid avoidance with either alemtuzumab or basiliximab induction in renal transplantation, Am J Transplant, vol.12, pp.919-931, 2012.

C. Liu, H. Noorchashm, J. A. Sutter, M. Naji, E. L. Prak et al., B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates, Nat Med, vol.13, pp.1295-1298, 2007.

A. De-masson, J. D. Bouaziz, L. Buanec, H. , R. M. O'meara et al., CD24(hi)CD27 + and plasmablastlike regulatory B cells in human chronic graft-versus-host disease, Blood, vol.125, pp.1830-1839, 2015.

Y. I. Jeong, S. H. Hong, S. H. Cho, W. J. Lee, and S. E. Lee, Induction of IL-10-producing CD1dhighCD5+ regulatory B cells following Babesia microti-infection, PLoS One, vol.7, p.46553, 2012.